Dicerna Pharmaceuticals Inc. (DRNA) Rose 5.67% or 0.57 To Price $10.63 On Friday


Dicerna Pharmaceuticals Inc. (DRNA) rose 5.67% or 0.57 to $10.63. It is nearly 414594 shares traded, which is 107.67% compare to the average total volume 385049. The market cap of DRNA is $548.95 million. The year to date change is 7.48%. The 52 week price range is from $2.52 to $11.19. Price of DRNA have changed 0.42% during last week. It have changed 10.98% over last month, 2.13% over last 3 months, 200.00% over last 6 months and 198.14% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for DRNA is 8.92. It is -16.09% below current price. The 200-day Moving Averages for DRNA is 5.59. It is -47.41% below current price. The 52-week High is 11.19. It is 5.27% from the current price. The 52-week Low is 2.52. It is -76.29% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of DRNA is 0.74 on 2018-01-31. Short % to float is 0.65%. There are some statistics of DRNA. It is has market cap $548.95 million. The share outstanding is 51.64 million. The average volume is 385049. The revenue is 992000. The percent of top 15 Institution holding is 64.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of DRNA is -275.97%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of DRNA is -96.12%.


Tags:

Share this post